Drug Shortage Report for SUCCINYLCHOLINE CHLORIDE INJECTION USP

Last updated on 2021-03-13 History
Report ID 85107
Drug Identification Number 02422336
Brand name SUCCINYLCHOLINE CHLORIDE INJECTION
Common or Proper name Succinylcholine Chloride
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SUCCINYLCHOLINE CHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20ML
ATC code M03AB
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-05-28
Actual start date 2019-05-28
Estimated end date 2021-03-12
Actual end date 2021-03-12
Shortage status Resolved
Updated date 2021-03-13
Company comments Product is now available at wholesalers for Hospital use only. Allocation is set at 100%-200% of historical demands based on region.
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-05-28 English Compare
v2 2019-05-28 French Compare
v3 2019-05-29 English Compare
v4 2019-06-05 English Compare
v5 2019-06-05 French Compare
v6 2019-06-21 English Compare
v7 2019-06-21 French Compare
v8 2019-08-13 English Compare
v9 2019-08-13 French Compare
v10 2019-08-30 English Compare
v11 2019-08-30 French Compare
v12 2019-09-09 English Compare
v13 2019-09-09 French Compare
v14 2019-09-17 English Compare
v15 2019-09-17 French Compare
v16 2019-09-24 English Compare
v17 2019-09-24 French Compare
v18 2019-10-03 English Compare
v19 2019-10-03 French Compare
v20 2020-01-03 English Compare

Showing 1 to 20 of 42